Skip to main content
SpringerLink
Log in

Sarkopenie

  • Chapter
  • First Online:
Neurogeriatrie

Zusammenfassung

Die Sarkopenie ist durch einen Verlust von Muskelmasse und Muskelkraft bzw. Muskelfunktion im Kontext des Alterns definiert. Da die Sarkopenie ein klinisches Phänomen älterer Patienten ist, eine hohe Prävalenz besitzt, eine multifaktorielle Genese aufweist, mit weiteren Komorbiditäten assoziiert und mit einem schlechten Outcome verbunden ist, wird sie als geriatrisches Syndrom betrachtet. Da die Sarkopenie auch durch einen Verlust von Motoneuronen und Degeneration der neuromuskulären Endplatte bedingt zu sein scheint, also neurodegenerative Ursachen hat, ist dieses Syndrom auch für die Neurogeriatrie relevant. Seit Oktober 2016 gibt es die Möglichkeit in den USA, die Sarkopenie in der ICD-10-CM zu kodieren (M62.84). In Deutschland gibt es den Code (M62.5) seit 2018. Aufgrund des syndromalen Charakters der Sarkopenie bietet die ICF eine gute Möglichkeit, das Syndrom nicht nur aus Sicht der Muskulatur, sondern auch mit Auswirkungen auf Mobilität, soziale Teilhabe, Umwelt und Persönlichkeit zu beschreiben.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Anker SD, Morley JE, Haehling S von (2016) Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle 7(5):512–514

    Article  Google Scholar 

  • Argilés JM, Anker SD, Evans WJ, Morley JE, Fearon KCH, Strasser F, Muscaritoli M, Baracos VE (2010) Consensus on cachexia definitions. J Am Med Dir Assoc 11(4):229–230

    Article  Google Scholar 

  • Bauer JM, Verlaan S, Bautmans I, Brandt K, Donini LM, Maggio M, McMurdo MET, Mets T, Seal C, Wijers SL, Ceda GP, De Vito G, Donders G, Drey M, Greig C, Holmbäck U, Narici M, McPhee J, Poggiogalle E, Power D, Scafoglieri A, Schultz R, Sieber CC, Cederholm T (2015) Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the provide study: a randomized, double-blind, placebo-controlled trial. J Am Med Dir Assoc 16(9):740–747

    Article  Google Scholar 

  • Baum JI, Kim IY, Wolfe RR (2016) Protein consumption and the elderly: what is the optimal level of intake? Nutrients 8(6):1–9

    Article  Google Scholar 

  • Beaudart C, Rizzoli R, Bruyère O, Reginster J-Y, Biver E (2014) Sarcopenia: burden and challenges for public health. Arch Public Health 72(1):45

    Article  Google Scholar 

  • Beaudart C, Biver E, Reginster JY, Rizzoli R, Rolland Y, Bautmans I, Petermans J, Gillain S, Buckinx F, Van Beveren J, Jacquemain M, Italiano P, Dardenne N, Bruyere O (2015) Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age Ageing 44(6):960–966

    Article  Google Scholar 

  • Beaudart C, McCloskey E, Bruyère O, Cesari M, Rolland Y, Rizzoli R, Araujo de Carvalho I, Amuthavalli Thiyagarajan J, Bautmans I, Bertière M-C, Brandi ML, Al-Daghri NM, Burlet N, Cavalier E, Cerreta F, Cherubini A, Fielding R, Gielen E, Landi F, Petermans J, Reginster J-Y, Visser M, Kanis J, Cooper C (2016) Sarcopenia in daily practice: assessment and management. BMC Geriatr 16(1):170

    Article  Google Scholar 

  • Beaudart C, Biver E, Reginster JY, Rizzoli R, Rolland Y, Bautmans I, Petermans J, Gillain S, Buckinx F, Dardenne N, Bruyère O (2017a) Validation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia. J Cachexia Sarcopenia Muscle 8(2):238–244

    Article  Google Scholar 

  • Beaudart C, Dawson A, Shaw SC, Harvey NC, Kanis JA, Binkley N, Reginster JY, Chapurlat R, Chan DC, Bruyère O, Rizzoli R, Cooper C, Dennison EM, Adib G, Brandi ML, Chevalley T, Clark P, Dawson-Hughes B, El Maghraoui A, Engelke K, Fielding R, Foldes AJ, Gugliemi G, Kaufman JM, Larijani B, Lems W, van Loon LJC, Lyritis GP, Maggi S, Masi L, McCloskey E, Messina OD, Papaioannou A, Szulc P, Veronese N (2017b) Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporos Int 28(6):1817–1833

    Article  CAS  Google Scholar 

  • Beaudart C, Locquet M, Reginster J-Y, Delandsheere L, Petermans J, Bruyère O (2017c) Quality of life in sarcopenia measured with the SarQoL®: impact of the use of different diagnosis definitions. Aging Clin Exp Res 30(4):307–313

    Google Scholar 

  • Beaudart C, Zaaria M, Pasleau F, Reginster J, Bruyère O (2017d) Health outcomes of sarcopenia: a systematic review and meta-analysis. Wright JM, ed. PLoS One 12(1):e0169548

    Google Scholar 

  • Becker C, Lord SR, Studenski SA, Warden SJ, Fielding RA, Recknor CP, Hochberg MC, Ferrari SL, Blain H, Binder EF, Rolland Y, Poiraudeau S, Benson CT, Myers SL, Hu L, Ahmad QI, Pacuch KR, Gomez E V, Benichou O, STEADY Group (2015) Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial. Lancet Diabetes Endocrinol 3(12):948–957

    Google Scholar 

  • Brown DM, Goljanek-Whysall K (2015) MicroRNAs: modulators of the underlying pathophysiology of sarcopenia? Ageing Res Rev 24:263–273

    Article  CAS  Google Scholar 

  • Burns JM, Donnelly JE, Anderson HS, Mayo MS, Spencer-Gardner L, Thomas G, Cronk BB, Haddad Z, Klima D, Hansen D, Brooks WM (2007) Peripheral insulin and brain structure in early Alzheimer disease. Neurology 69(11):1094–1104

    Article  CAS  Google Scholar 

  • Burns JM, Johnson DK, Watts A, Swerdlow RH, Brooks WM (2010) Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch Neurol 67(4):428–433

    Article  Google Scholar 

  • Cardon-Thomas DK, Riviere T, Tieges Z, Greig CA (2017) Dietary protein in older adults: adequate daily intake but potential for improved distribution. Nutrients 9(3):1–10

    Article  Google Scholar 

  • Cetrone M, Mele A, Tricarico D (2014) Effects of the antidiabetic drugs on the age-related atrophy and sarcopenia associated with diabetes type II. Curr Diabetes Rev 10(4):231–237

    Article  CAS  Google Scholar 

  • Chang K-V, Hsu T-H, Wu W-T, Huang K-C, Han D-S (2017) Is sarcopenia associated with depression? A systematic review and meta-analysis of observational studies. Age Ageing 46(5):1–9.

    Google Scholar 

  • Chang S-F, Lin P-L (2016) Systematic literature review and meta-analysis of the association of sarcopenia with mortality. Worldviews Evidence-Based Nurs 13(2):153–162

    Article  Google Scholar 

  • Clark BC (2012) Manini and TM. What is dynapenia? Nutrition 28(5):495–503

    Article  Google Scholar 

  • Corbett DB, Rejeski WJ, Tudor-Locke C, Glynn NW, Kritchevsky SB, McDermott MM, Church TS, Fielding RA, Gill TM, King AC, Miller ME, Chen H, Pahor M, Manini TM (2017) Social participation modifies the effect of a structured physical activity program on major mobility disability among older adults: results from the LIFE study. J Gerontol Ser B 00(00):1–13

    Google Scholar 

  • Corcoran MP, Nelson ME, Sacheck JM, Reid KF, Kirn D, Fielding RA, Folta SC (2016) Recruitment of mobility limited older adults into a facility-led exercise-nutrition study: the effect of social involvement. Gerontologist 56(4):669–676

    Google Scholar 

  • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M (2010) Sarcopenia: European consensus on definition and diagnosis. Age Ageing 39(4):412–423

    Google Scholar 

  • Cruz-Jentoft AJ, Landi F, Topinková E, Michel J-P (2010) Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 13(1):1–7

    Google Scholar 

  • Dalton JT, Barnette KG, Bohl CE, Hancock ML, Rodriguez D, Dodson ST, Morton RA, Steiner MS (2011) The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle 2(3):153–161

    Google Scholar 

  • Demakakos P, Cooper R, Hamer M, Oliveira C de, Hardy R, Breeze E (2013) The bidirectional association between depressive symptoms and gait speed: evidence from the english longitudinal study of ageing (ELSA). Bayer A, ed. PLoS One 8(7):e68632

    Google Scholar 

  • Dodds RM, Roberts HC, Cooper C, Sayer AA (2016) The epidemiology of sarcopenia. J Clin Densitom 18(4):461–466

    Article  Google Scholar 

  • Drey M, Hasmann SE, Krenovsky J-P, Hobert MA, Straub S, Elshehabi M, von Thaler A-K, Fallgatter AJ, Eschweiler GW, Suenkel U, Berg D, Maetzler W (2017) Associations between early markers of Parkinson’s disease and sarcopenia. Front Aging Neurosci 9

    Google Scholar 

  • Fiatarone MA, Marks EC, Ryan ND, Meredith CN, Lipsitz LA, Evans WJ (1990) High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA 263(22):3029–3034

    Article  CAS  Google Scholar 

  • Gillespie LD, Robertson MC, Gillespie WJ, Sherrington C, Gates S, Clemson LM, Lamb SE (2012) Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev

    Google Scholar 

  • Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, Simonsick EM, Tylavsky FA, Visser M, Newman AB (2006) The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 61(10):1059–1064

    Article  Google Scholar 

  • Greenberg SA (2012) Analysis of measurement tools of fear of falling for high-risk, community-dwelling older adults. Clin Nurs Res 21(1):113–130

    Article  Google Scholar 

  • Hassan EB, Duque G (2017) Osteosarcopenia: a new geriatric syndrome. Aust Fam Physician 46(11):849–853

    PubMed  Google Scholar 

  • Huo YR, Suriyaarachchi P, Gomez F, Curcio CL, Boersma D, Gunawardene P, Demontiero O, Duque G (2015) Comprehensive nutritional status in sarco-osteoporotic older fallers. J Nutr Heal Aging 19(4):474–480

    Article  CAS  Google Scholar 

  • Ikizler TA, Cano NJ, Franch H, Fouque D, Himmelfarb J, Kalantar-Zadeh K, Kuhlmann MK, Stenvinkel P, Terwee P, Teta D, Wang AYM, Wanner C (2013) Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the international society of renal nutrition and metabolism. Kidney Int 84(6):1096–1107

    Article  CAS  Google Scholar 

  • Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R (2004) The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 52(1):80–85

    Article  Google Scholar 

  • Kemmler W, Sieber C, Freiberger E, von Stengel S (2017) The SARC-F questionnaire: diagnostic overlap with established sarcopenia definitions in older German men with sarcopenia. Gerontology 63(5):411–416

    Article  Google Scholar 

  • Kortebein P, Ferrando A, Lombeida J, Wolfe R, Evans WJ (2007) Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA 297(16):1769

    Article  Google Scholar 

  • Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E, Bernabei R, Onder G (2012) Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 31(5):652–658

    Article  Google Scholar 

  • Maeda K, Akagi J (2016a) Sarcopenia is an independent risk factor of dysphagia in hospitalized older people. Geriatr Gerontol Int 16(4):515–521

    Article  Google Scholar 

  • Maeda K, Akagi J (2016b) Treatment of sarcopenic dysphagia with rehabilitation and nutritional support: a comprehensive approach. J Acad Nutr Diet 116(4):573–577

    Article  Google Scholar 

  • Maeda K, Takaki M, Akagi J (2016) Decreased skeletal muscle mass and risk factors of sarcopenic dysphagia: a prospective observational cohort study. J Gerontol Ser A Biol Sci Med Sci 72(9):1290–1294

    Google Scholar 

  • Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE (2016) SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 7(1):28–36

    Article  Google Scholar 

  • Marty E, Liu Y, Samuel A, Or O, Lane J (2017) A review of sarcopenia: enhancing awareness of an increasingly prevalent disease. Bone 105:276–286

    Article  Google Scholar 

  • McLean RR, Shardell MD, Alley DE, Cawthon PM, Fragala MS, Harris TB, Kenny AM, Peters KW, Ferrucci L, Guralnik JM, Kritchevsky SB, Kiel DP, Vassileva MT, Xue Q-L, Perera S, Studenski SA, Dam T-TL (2014) Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A Biol Sci Med Sci 69(5):576–583

    Google Scholar 

  • Morley JE (2016) Pharmacologic options for the treatment of sarcopenia. Calcif Tissue Int 98(4):319–333

    Article  CAS  Google Scholar 

  • Papa EV, Dong X, Hassan M (2017) Resistance training for activity limitations in older adults with skeletal muscle function deficits: a systematic review. Clin Interv Aging 12:955–961

    Article  Google Scholar 

  • Peters A (2011) The selfish brain: competition for energy resources. Am J Hum Biol 23(1):29–34

    Article  Google Scholar 

  • Peterson MD, Sen A, Gordon PM (2011) Influence of resistance exercise on lean body mass in aging adults: a meta-analysis. Med Sci Sports Exerc 43(2):249–258

    Article  Google Scholar 

  • Phillips A, Strobl R, Vogt S, Ladwig KH, Thorand B, Grill E (2017) Sarcopenia is associated with disability status – results from the KORA-Age study. Osteoporos Int 28(7):2069–2079

    Article  CAS  Google Scholar 

  • Rooks D, Praestgaard J, Hariry S, Laurent D, Petricoul O, Perry RG, Lach-Trifilieff E, Roubenoff R (2017) Treatment of sarcopenia with bimagrumab: results from a Phase II, randomized, controlled, proof-of-concept study. J Am Geriatr Soc 65(9):1988–1995

    Article  Google Scholar 

  • Rosenberg IH (1989) Summary comment. Am J Clin Nutr 50:1231–1233

    Article  Google Scholar 

  • Scalzo P, Kümmer A, Cardoso F, Teixeira AL (2010) Serum levels of interleukin-6 are elevated in patients with Parkinson’s disease and correlate with physical performance. Neurosci Lett 468(1):56–58

    Article  CAS  Google Scholar 

  • Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R (2017) Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. J Diabetes Metab Disord 16(1):21

    Article  Google Scholar 

  • Shaw SC, Dennison EM, Cooper C (2017) Epidemiology of sarcopenia: determinants throughout the lifecourse. Calcif Tissue Int 101(3):229–247

    Article  CAS  Google Scholar 

  • Tang TC, Hwang AC, Liu LK, Lee WJ, Chen LY, Wu YH, Huang CY, Hung CH, Wang CJ, Lin MH, Peng LN, Chen LK (2017) FNIH-defined sarcopenia predicts adverse outcomes among community-dwelling older people in Taiwan: results from I-Lan longitudinal aging study. J Gerontol A Biol Sci Med Sci 73(6):828–834

    Google Scholar 

  • Tramontano A, Veronese N, Sergi G, Manzato E, Rodriguez-Hurtado D, Maggi S, Trevisan C, De Zaiacomo F, Giantin V, Beaudart C, Rizzoli R, Bruyère O, Reginster J-Y, Biver E (2014) Prevalence of sarcopenia and associated factors in the healthy older adults of the Peruvian Andes. Arch Public Health 68(1):45

    Google Scholar 

  • Tramontano A, Veronese N, Sergi G, Manzato E, Rodriguez-Hurtado D, Maggi S, Trevisan C, De Zaiacomo F, Giantin V (2017) Prevalence of sarcopenia and associated factors in the healthy older adults of the Peruvian Andes. Arch Gerontol Geriatr 68:49–54

    Article  Google Scholar 

  • Tsekoura M, Kastrinis A, Katsoulaki M, Billis E, Gliatis J (2017) Sarcopenia and its impact on quality of life. In: Vlamos P, ed.Vol 987. Advances in Experimental Medicine and Biology. Cham: Springer International Publishing 213–218.

    Google Scholar 

  • Uitti RJ (1995) The etiology of idiopathic parkinsonism. Parkinsonism Relat Disord 1(2):65–66

    Article  CAS  Google Scholar 

  • Volpato S, Bianchi L, Cherubini A, Landi F, Maggio M, Savino E, Bandinelli S, Ceda GP, Guralnik JM, Zuliani G, Ferrucci L (2014) Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci 69(4):438–446

    Article  CAS  Google Scholar 

  • Wettstein M, Wahl H-W, Diehl MK (2014) A multidimensional view of out-of-home behaviors in cognitively unimpaired older adults: examining differential effects of socio-demographic, cognitive, and health-related predictors. Eur J Ageing 11(2):141–153

    Article  Google Scholar 

  • Woo J, Leung J, Morley JE (2014) Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc 15(9):630–634

    Article  Google Scholar 

  • Wright SL, Kay RE, Avery ET, Giordani B, Alexander NB (2011) The impact of depression on dual tasking among patients with high fall risk. J Geriatr Psychiatry Neurol 24(3):142–150

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Klinik und Poliklinik IV, Klinikum der Universtiät München, München, Deutschland

    Michael Drey & Uta Ferrari

  2. Klinik für Neurologie, UKSH, Campus Kiel, Kiel, Deutschland

    Walter Maetzler

Authors
  1. Michael Drey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Walter Maetzler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Uta Ferrari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Drey .

Editor information

Editors and Affiliations

  1. Klinik für Neurologie, UKSH, Campus Kiel, Kiel, Germany

    Walter Maetzler

  2. Lehrstuhl für Geriatrie, Universitätsklinikum Essen, Geriatriezentrum Haus Berge, Contilia Group, Essen, Germany

    Richard Dodel

  3. Klinik für Geriatrie mit Neurologie, Johanniter Krankenhaus Bonn, Bonn, Germany

    Andreas H. Jacobs

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Drey, M., Maetzler, W., Ferrari, U. (2019). Sarkopenie. In: Maetzler, W., Dodel, R., Jacobs, A. (eds) Neurogeriatrie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57358-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-57358-7_6

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-57357-0

  • Online ISBN: 978-3-662-57358-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation